ProMIS Neurosciences Inc. (PMN) stock forecast and price target
Price $3.29 · data as of November 13, 2026
12-month price target
Average target$42.31
Upside / downside+1186.0%
Analysts6
ConsensusStrong buy
Low $14.96Average $42.31High $99.80
Gold marker: average target · white marker: today’s price ($3.29)
Analyst ratings
Strong buy 1Buy 6Hold 0Sell 0Strong sell 0
Earnings and revenue estimates
| Period | EPS estimate | EPS growth | Revenue estimate |
|---|---|---|---|
| Current fiscal year ends December 31, 2026 | $-6.14 | — | $0 |
| Next fiscal year ends December 31, 2027 | $-5.02 | +7.6% | $0 |
| Next quarter ends December 31, 2026 | $-1.31 | — | $0 |
| Quarter after ends March 31, 2027 | $-1.46 | — | $0 |
Consensus of the analysts covering ProMIS Neurosciences, updated daily.
Frequently asked questions
What is the ProMIS Neurosciences stock price target?
The average 12-month target from 6 analysts is $42.31, 1186.0% above the current price of $3.29 Targets range from $14.96 to $99.80.
Is ProMIS Neurosciences a buy according to analysts?
The consensus rating is “Strong buy” (1 strong buy, 6 buy). Ratings are opinions, not guarantees; this is not investment advice.
How much is ProMIS Neurosciences expected to earn?
Analysts expect EPS of $-6.14 for the fiscal year ending December 31, 2026 and $-5.02 the year after.
Analyst consensus estimates and price targets, updated daily. Forecasts can be wrong; this is information, not investment advice.